Core One Labs (XCNQ:COOL) Total Current Assets : C$0.45 Mil (As of Dec. 2023)

View and export this data going back to 2011. Start your Free Trial

What is Core One Labs Total Current Assets?

Total current assets includes Cash, Cash Equivalents, Marketable Securities, Total Receivables, Total Inventories, and Other Current Assets. Core One Labs's total current assets for the quarter that ended in Dec. 2023 was C$0.45 Mil.

Core One Labs Total Current Assets Historical Data

The historical data trend for Core One Labs's Total Current Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Core One Labs Total Current Assets Chart

Core One Labs Annual Data

Trend

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Total Current Assets

Get a 7-Day Free Trial

3.06

3.87

3.76

4.99

1.16

Core One Labs Quarterly Data
	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Sep23	Dec23
Total Current Assets	Get a 7-Day Free Trial															0.56	0.51	-	0.53	0.45

Core One Labs Total Current Assets Calculation

Total Current Assets are the asset that can be converted to cash or used to pay current liabilities within 12 months.

Core One Labs's Total Current Assets for the fiscal year that ended in Dec. 2021 is calculated as

Total Current Assets	=	Cash, Cash Equivalents, Marketable Securities	+	Total Receivables	+	Total Inventories	+	Other Current Assets
	=	0.873	+	0.214	+	0.003	+	0.072
	=	1.16

Core One Labs's Total Current Assets for the quarter that ended in Dec. 2023 is calculated as

Total Current Assets	=	Cash, Cash Equivalents, Marketable Securities	+	Total Receivables	+	Total Inventories	+	Other Current Assets
	=	0.155	+	0.225	+	0.001	+	0.065
	=	0.45

Total Current Assets is linked to the Current Ratio, which is the result of dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations.

Total Current Assets is also linked to Working Capital, Net working capital is calculated as Total Current Assets minus Total Current Liabilities.

Core One Labs (XCNQ:COOL) Total Current Assets Explanation

In Ben Graham's calculation of liquidation value, inventory is only considered worth half of its book value, and accounts receivable is considered worth 75% of its value. Therefore the liquidation value is lower than calculated from total current assets.

Core One Labs's Liquidation Value for the quarter that ended in Dec. 2023 is

	Liquidation value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	0.155	-	1.759	+	0.75 * 0.021	+	0.5 * 0.001
=	-1.59

Core One Labs Total Current Assets Related Terms

Thank you for viewing the detailed overview of Core One Labs's Total Current Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Core One Labs Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Core One Labs Inc (XCNQ:COOL) » Definitions » Total Current Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

1199 West Hastings Street, Suite 800, Vancouver, BC, CAN, V6E 3T5

Website

https://www.core1labs.com

Core One Labs Inc is a psychedelic research and development life sciences enterprise focused on bringing psychedelic medicines to market through novel delivery systems and psychedelic assisted psychotherapy. The company intends to further develop and apply the technology to psychedelic compounds, such as psilocybin. The Company operates a virtual clinic that assesses patients for the appropriateness of treatment plans for the use of medical cannabis to treat their symptoms. The Company partners with physicians and Health Canada's licensed producers for the provision of treatments, fulfillment of prescriptions, and sale of related products.

Executives

Geoffrey Balderson	Director, Senior Officer
Joel Shacker	Director, Senior Officer
Robert E.w. Hancock	Director
Brad Eckenweiler	10% Security Holder, Director, Senior Officer